@bhaumik

If curing stage IV breast cancer isn't a compelling hook... Eric has the team, persistence, and unique approach to tackle a $75b/year market opportunity (US alone). He's facing a chicken-or-egg problem in that top tier VC's think they're a bit early too invest but need funding to complete 6-12 months of studies before beginning human trials.

1 reply

1 recast

1 reaction